$172,206
＋3.5%
Chief Science Officer
2024
$166k org
40 hrs/wk
$7k other
--
Chief Science Officer at The Fibrolamellar Cancer Foundation
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Dr Mark Furth has been listed as an employee of The Fibrolamellar Cancer Foundation in Form 990 filings since fiscal year 2019. Total compensation for Dr Mark Furth has increased by 11% from 2019 to 2024.